Joint venture between Maire and Newcleo for the development of advanced nuclear technologies

McDermott Will & Emery advised Maire. Maire’s in-house legal team supported the transaction. Maire, through its subsidiary Nextchem, and Newcleo SA, a company active in innovation…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here